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ABSTRACT 
Lovastatin is widely prescribed to reduce elevated levels of cholesterol and prevent heart-
related diseases. Cultivation of Aspergillus terreus (ATCC 20542) with carbohydrates or low-
value feedstocks such as glycerol produces lovastatin as a secondary metabolite and (+)-
geodin as a by-product. An A. terreus mutant strain was developed (gedCΔ) with a disrupted 
(+)-geodin biosynthesis pathway. The gedCΔ mutant was created by inserting the antibiotic 
marker hygromycin B (hyg) within the gedC gene that encodes emodin anthrone polyketide 
synthase (PKS), a primary gene responsible for initiating (+)-geodin biosynthesis. The effects 
of emodin anthrone PKS gene disruption on (+)-geodin and lovastatin biosynthesis and the 
production of the precursors acetyl-CoA and malonyl-CoA were investigated with cultures 
based on glycerol alone and in combination with lactose. The gedCΔ strain showed improved 
lovastatin production, particularly when cultivated on the glycerol-lactose mixture, increasing 
lovastatin production by 80% (113 mg/L) while simultaneously inhibiting (+)-geodin 
biosynthesis compared to the wild-type strain. This study thus shows that suppression of the 
(+)-geodin pathway increases lovastatin yield and demonstrates a practical approach of 
manipulating carbon flux by modulating enzyme activity. 
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